Incidence and Determinants of QT Interval Prolongation in
COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin
Ilir Maraj1,2*, James P Hummel1*,
Roy Taoutel1, Romy Chamoun1,
Virginia Workman1, Cindy Li3, Lydia
Tran3, Alexander DelVecchio2,
Christopher Howes1,2, Joseph G
Akar1,2
- Department of Internal Medicine, Cardiovascular Medicine, Yale School
of Medicine, New Haven, CT
- Department of Internal Medicine, Greenwich Hospital, Greenwich, CT
- Department of Pharmacy Services, Yale New Haven Hospital, New Haven,
CT
*Authors contributed equally